LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

Search

Cencora Inc

Closed

SectorHealthcare

351.47 -3.88

Overview

Share price change

24h

Current

Min

346.58

Max

374.74

Key metrics

By Trading Economics

Income

906M

566M

Sales

2.2B

86B

P/E

Sector Avg

43.662

121.746

EPS

2.87

Dividend yield

0.63

Profit margin

0.659

Employees

47,000

EBITDA

858M

1B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+14.34% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.63%

2.26%

Next Earnings

6 maj 2026

Next Dividend date

2 mar 2026

Next Ex Dividend date

13 lut 2026

Market Stats

By TradingEconomics

Market Cap

-55M

71B

Previous open

355.35

Previous close

351.47

News Sentiment

By Acuity

34%

66%

96 / 352 Ranking in Healthcare

Cencora Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 lut 2026, 23:57 UTC

Hot Stocks

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12 lut 2026, 23:35 UTC

Earnings
Major Market Movers

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12 lut 2026, 23:28 UTC

Earnings

Applied Materials Profit Rises on Soaring AI Demand -- Update

12 lut 2026, 21:47 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13 lut 2026, 00:00 UTC

Market Talk

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12 lut 2026, 23:47 UTC

Market Talk

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12 lut 2026, 23:38 UTC

Market Talk

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12 lut 2026, 23:33 UTC

Earnings

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12 lut 2026, 23:09 UTC

Market Talk

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12 lut 2026, 22:55 UTC

Earnings
Hot Stocks

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12 lut 2026, 22:46 UTC

Market Talk

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12 lut 2026, 22:23 UTC

Earnings

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12 lut 2026, 22:00 UTC

Earnings

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12 lut 2026, 22:00 UTC

Earnings

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12 lut 2026, 21:57 UTC

Earnings

XP 4Q Rev BRL4.95B >XP

12 lut 2026, 21:52 UTC

Earnings

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 lut 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

12 lut 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 lut 2026, 21:47 UTC

Earnings

Morningstar 4Q Rev $641M >MORN

12 lut 2026, 21:39 UTC

Earnings

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 lut 2026, 21:38 UTC

Earnings

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Peer Comparison

Price change

Cencora Inc Forecast

Price Target

By TipRanks

14.34% upside

12 Months Forecast

Average 415.38 USD  14.34%

High 440 USD

Low 400 USD

Based on 9 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Sentiment

By Acuity

96 / 352 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat